Artbio in a $132 million Series B deal co-led by Sofinnova Investments and B Capital, joined by F-Prime, Omega Funds, and Third Rock Ventures.
05 July 2025
05 July 2025
Total investments received (USD): 245M
Round value (USD): 132M
Company: Artbio
Related deals
ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion
M&A
12 October 2025
Adcytherix raised €105m in Series A from Andera Partners, Angelini Ventures, Kurma Partners, Surveyor Capital, aMoon, Pontifax, DawnBiopharma, RA Capital.
Investments
03 October 2025
OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion
Secondary
14 July 2025
Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.
Investments
07 June 2025
GlycoEra raised $130m in Series B led by Novo, joined by Catalio Capital, LifeArc Ventures, QIA, Sixty Degree Capital, Agent Capital, MP Healthcare, Sofinnova.
Investments
17 May 2025
Belgium
Netherlands
Austria
Germany
Estonia
Finland
Iceland
Latvia
Lithuania
Sweden
Ireland
Portugal
Spain